THC Stock Overview
THC Biomed Intl Ltd. produces and sells medical and recreational cannabis in Canada.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
THC Biomed Intl Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.02 |
| 52 Week High | CA$0.055 |
| 52 Week Low | CA$0.01 |
| Beta | 0.38 |
| 1 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | -55.56% |
| 3 Year Change | -85.71% |
| 5 Year Change | -92.86% |
| Change since IPO | -99.81% |
Recent News & Updates
Recent updates
Does THC Biomed Intl (CSE:THC) Have A Healthy Balance Sheet?
Oct 11
Is THC Biomed Intl (CSE:THC) Weighed On By Its Debt Load?
Jun 26Is THC Biomed Intl (CSE:THC) Weighed On By Its Debt Load?
Mar 13Is THC Biomed Intl (CSE:THC) Using Too Much Debt?
Aug 30We Think THC Biomed Intl (CSE:THC) Has A Fair Chunk Of Debt
Mar 25Does THC Biomed Intl (CSE:THC) Have A Healthy Balance Sheet?
Dec 02Is THC Biomed Intl (CSE:THC) Using Too Much Debt?
Jun 01Analysts Expect Breakeven For THC Biomed Intl Ltd. (CSE:THC) Before Long
Apr 06Would THC Biomed Intl (CSE:THC) Be Better Off With Less Debt?
Jan 08Shareholder Returns
| THC | CA Pharmaceuticals | CA Market | |
|---|---|---|---|
| 7D | 0% | -4.9% | -1.9% |
| 1Y | -55.6% | 55.7% | 3.7% |
Return vs Industry: THC underperformed the Canadian Pharmaceuticals industry which returned 58% over the past year.
Return vs Market: THC underperformed the Canadian Market which returned 3.6% over the past year.
Price Volatility
| THC volatility | |
|---|---|
| THC Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 14.1% |
| Market Average Movement | 9.1% |
| 10% most volatile stocks in CA Market | 18.3% |
| 10% least volatile stocks in CA Market | 3.1% |
Stable Share Price: THC's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine THC's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2012 | 35 | John Miller | thcbiomed.com |
THC Biomed Intl Ltd. produces and sells medical and recreational cannabis in Canada. It offers cannabis beverage shots, gummies, and biscuits under the THC KISS brand names, as well as pure cannabis sticks. The company was founded in 2012 and is headquartered in Kelowna, Canada.
THC Biomed Intl Ltd. Fundamentals Summary
| THC fundamental statistics | |
|---|---|
| Market cap | CA$3.28m |
| Earnings (TTM) | -CA$3.67m |
| Revenue (TTM) | CA$2.23m |
1.5x
P/S Ratio-0.9x
P/E RatioIs THC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| THC income statement (TTM) | |
|---|---|
| Revenue | CA$2.23m |
| Cost of Revenue | CA$3.39m |
| Gross Profit | -CA$1.16m |
| Other Expenses | CA$2.51m |
| Earnings | -CA$3.67m |
Last Reported Earnings
Apr 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.022 |
| Gross Margin | -52.14% |
| Net Profit Margin | -164.79% |
| Debt/Equity Ratio | 91.8% |
How did THC perform over the long term?
See historical performance and comparison